Hong Kong Commercial Services Stock News

As global markets face volatility, particularly in the technology sector, Asian markets have shown resilience with Chinese indices reaching new highs amid easing trade tensions. In this environment, growth companies with high insider ownership can be appealing as they often indicate strong confidence from those who know the business best and may offer stability amidst broader market fluctuations.

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

When researching a stock for investment, what can tell us that the company is in decline? Typically, we'll see the...

Despite an already strong run, BeijingWest Industries International Limited ( HKG:2339 ) shares have been powering on...

As global markets face a mix of challenges, including concerns over elevated valuations and increased scrutiny around AI spending, the Asian tech sector has shown resilience with mainland Chinese stock markets recently edging higher due to easing U.S.-China trade tensions. In this environment, identifying high-growth tech stocks requires a keen focus on companies that not only demonstrate strong innovation and adaptability but also have the potential to thrive amid evolving geopolitical...

Despite an already strong run, Sun.King Technology Group Limited ( HKG:580 ) shares have been powering on, with a gain...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Gilston Group Limited ( HKG:2011 ) shareholders would be excited to see that the share price has had a great month...

Key Insights Cheuk Nang (Holdings) to hold its Annual General Meeting on 20th of November Salary of HK$9.72m is part of...

3SBio Inc. ( HKG:1530 ) shareholders would be excited to see that the share price has had a great month, posting a 28...

Key Insights Ngai Hing Hong will host its Annual General Meeting on 20th of November Total pay for CEO Kwok Kwong Hui...

RemeGen Co., Ltd. reported earnings for the nine months ended September 30, 2025, with sales and revenue rising to CNY 1,719.83 million from CNY 1,208.87 million a year earlier, while its net loss narrowed to CNY 550.7 million from CNY 1,071.43 million. The company also reported that its basic and diluted loss per share from continuing operations dropped to CNY 1.01 from CNY 1.99 in the previous year. We'll explore how RemeGen’s reduced net loss and improved revenue shape its investment...

Tencent Holdings (SEHK:700) has drawn fresh attention from investors after launching new AI-powered services on its TanLIVE climate innovation platform. The recent announcement highlights Tencent’s ongoing efforts to develop climate solutions in collaboration with major global partners. See our latest analysis for Tencent Holdings. Tencent’s new climate innovation launch is making waves at a time when its share price momentum is hard to ignore. With a year-to-date share price return of nearly...

Shanghai MicroPort MedBot (Group) recently announced the resignation of three senior board members, including the chairperson, and proposed amendments to its board structure and governance documents, pending approval at an extraordinary general meeting. These governance changes mark a significant moment for the company, as leadership transitions and board expansion could reshape decision-making processes and future growth initiatives. We'll explore how these multiple high-level resignations...

On November 5, 2025, Ceres Power Holdings plc announced it has signed a manufacturing licence agreement with Weichai Power for the production of its solid oxide fuel cell technology, enabling Weichai to produce cells and stacks for stationary power systems in China targeting AI data centres, commercial buildings, and industrial sectors. This agreement not only expands Ceres' roster of manufacturing partners to four but also marks a shift for Weichai Power into advanced energy solutions that...

InnoCare Pharma (SEHK:9969) just reported higher sales and a smaller net loss for the first nine months of 2025, while also advancing key drug candidates in its clinical pipeline. This combination is catching investor attention. See our latest analysis for InnoCare Pharma. Momentum has returned in a big way for InnoCare Pharma, with its share price rallying 5.08% over the past week and boasting a striking year-to-date gain of 165.38%. Even after a pullback in the last quarter, the total...

PICC Property and Casualty (SEHK:2328) recently held its Analyst and Investor Day, which followed the approval of an interim dividend for the first half of 2025. This timing brought renewed attention to the company’s financial health and strategic direction. See our latest analysis for PICC Property and Casualty. The combination of a freshly approved interim dividend and a recent Analyst and Investor Day appears to have strengthened investor confidence. This is reflected in PICC Property and...

At EICMA 2025, Yadea Group Holdings unveiled its latest high-performance electric motorcycles and an integrated charging ecosystem, debuting innovations such as the Velax series with ultra-fast charging, next-generation sodium-ion batteries, and a range of intelligent mobility solutions. A key highlight is Yadea’s focus on making rapid charging and sodium battery technology widely accessible, underlining its ambitions to accelerate sustainable electric mobility on a global scale. As Yadea...

CNOOC (SEHK:883) just released its earnings report for the first nine months of 2025, highlighting a decline in both revenue and net income compared to the previous year. This development is catching investors’ attention. See our latest analysis for CNOOC. CNOOC's shares have had an impressive run, with a 20.7% share price return over the past month and a strong 44.4% total shareholder return for the past year, despite the recent earnings disappointment. Momentum remains solid, suggesting...

United Energy Group (SEHK:467) has received a ‘BB-’ credit rating from Fitch for its proposed US dollar notes, shortly after acquiring Apex International Energy’s Egypt assets for USD150 million. These moves reflect management’s focus on expansion and refining its capital structure. See our latest analysis for United Energy Group. Following the acquisition news and Fitch's rating, investor sentiment appears to be shifting. United Energy Group boasts a robust year-to-date share price return of...

Xiaomi (SEHK:1810) shares have been active in recent sessions, catching investor interest amid shifts in Hong Kong’s tech sector. Traders are considering how recent market conditions may affect Xiaomi’s performance and valuation in the coming months. See our latest analysis for Xiaomi. Xiaomi’s share price has pulled back by over 10% in the past month after some earlier momentum. It is still sitting on a remarkable year-to-date gain of nearly 28%. Even more striking, the stock’s one-year...

Genscript Biotech (SEHK:1548) just held its Analyst and Investor Day, a regular event where management updates shareholders on strategy and future plans. These sessions often spark renewed interest in the company’s growth prospects and valuation. See our latest analysis for Genscript Biotech. Following the Analyst and Investor Day, Genscript Biotech’s shares surged with a 1-day share price return of 5.86 percent. This added to its strong year-to-date momentum and suggested renewed investor...

Recent shifts in Guinea's mining sector, including new local processing mandates and transferred concessions, could impact global aluminum supply chains. For Aluminum Corporation of China (SEHK:2600), these changes may affect input costs and future supply stability. See our latest analysis for Aluminum Corporation of China. Aluminum Corporation of China’s momentum has been nothing short of remarkable. After a steady climb throughout the year, the share price has spiked by 161.85%...

Ascentage Pharma Group International (SEHK:6855) saw attention rise after announcing that new clinical and preclinical results on olverembatinib, lisaftoclax, and APG-5918 will be featured at the 67th ASH Annual Meeting. This recognition for its drug candidates highlights the company’s development programs and keeps them in focus for investors. See our latest analysis for Ascentage Pharma Group International. This spotlight at ASH comes after a year of strong momentum for Ascentage Pharma...